Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Liver Cirrhosis

  Free Subscription


30.12.2018

1 Clin Res Hepatol Gastroenterol
1 Dig Dis
6 Hepatology
2 Lancet Gastroenterol Hepatol
2 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Clin Res Hepatol Gastroenterol

  1. BERGERE M, Erard-Poinsot D, Boillot O, Valette PJ, et al
    Portal vein thrombosis and liver cirrhosis: Long-term anticoagulation is effective and safe.
    Clin Res Hepatol Gastroenterol. 2018 Dec 18. pii: S2210-7401(18)30268.
    PubMed     Text format     Abstract available


    Dig Dis

  2. SHIRIN D, Peleg N, Sneh-Arbib O, Cohen-Naftaly M, et al
    The Pattern of Elevated Liver Function Tests in Nonalcoholic Fatty Liver Disease Predicts Fibrosis Stage and Metabolic-Associated Comorbidities.
    Dig Dis. 2019;37:69-76.
    PubMed     Text format     Abstract available


    Hepatology

  3. KOSTALLARI E, Hirsova P, Prasnicka A, Verma VK, et al
    Hepatic stellate cell-derived PDGFRalpha-enriched extracellular vesicles promote liver fibrosis in mice through SHP2.
    Hepatology. 2018 Jan 23. doi: 10.1002/hep.29803.
    PubMed     Text format     Abstract available

  4. ORNOLFSSON KT, Olafsson S, Bergmann OM, Gershwin ME, et al
    Using the Icelandic Genealogical Database to define the familial risk of primary biliary cholangitis.
    Hepatology. 2017 Nov 21. doi: 10.1002/hep.29675.
    PubMed     Text format     Abstract available

  5. KANWAL F, Tapper EB, Ho C, Asrani SK, et al
    Development of Quality Measures in Cirrhosis by the Practice Metrics Committee of the American Association for the Study of Liver Diseases.
    Hepatology. 2018 Dec 26. doi: 10.1002/hep.30489.
    PubMed     Text format     Abstract available

  6. BERENGUER J, Gil-Martin A, Jarrin I, Moreno A, et al
    All-oral DAA therapy against HCV in HIV/HCV-coinfected subjects in real-world practice: Madrid-CoRe Findings.
    Hepatology. 2018 Jan 29. doi: 10.1002/hep.29814.
    PubMed     Text format     Abstract available

  7. YOUNOSSI ZM, Loomba R, Anstee QM, Rinella ME, et al
    Diagnostic Modalities for Non-alcoholic Fatty Liver Disease (NAFLD), Non-alcoholic Steatohepatitis (NASH) and Associated Fibrosis.
    Hepatology. 2017 Dec 9. doi: 10.1002/hep.29721.
    PubMed     Text format     Abstract available

  8. BOTTCHER K, Rombouts K, Saffioti F, Roccarina D, et al
    MAIT cells are chronically activated in patients with autoimmune liver disease and promote pro-fibrogenic hepatic stellate cell activation.
    Hepatology. 2018 Jan 12. doi: 10.1002/hep.29782.
    PubMed     Text format     Abstract available


    Lancet Gastroenterol Hepatol

  9. EZAZ G, Tapper EB
    Driving in the dark: cirrhosis in young adults.
    Lancet Gastroenterol Hepatol. 2018 Dec 17. pii: S2468-1253(18)30419.
    PubMed     Text format    

  10. FLEMMING JA, Dewit Y, Mah JM, Saperia J, et al
    Incidence of cirrhosis in young birth cohorts in Canada from 1997 to 2016: a retrospective population-based study.
    Lancet Gastroenterol Hepatol. 2018 Dec 17. pii: S2468-1253(18)30339.
    PubMed     Text format     Abstract available


    PLoS One

  11. ABE K, Takahashi A, Fujita M, Imaizumi H, et al
    Dysbiosis of oral microbiota and its association with salivary immunological biomarkers in autoimmune liver disease.
    PLoS One. 2018;13:e0198757.
    PubMed     Text format     Abstract available

  12. CHANG PE, Goh GBB, Leow WQ, Shen L, et al
    Second harmonic generation microscopy provides accurate automated staging of liver fibrosis in patients with non-alcoholic fatty liver disease.
    PLoS One. 2018;13:e0199166.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Liver Cirrhosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: